CC241129P14000
- 0.17
- 0.000.00%
The Chemours Newsroom
The Chemours Company Announces Completion of U.S. Dollar-denominated Term Loan Repricing
Express News | The Chemours Company Announces Completion of U.S. Dollar-Denominated Term Loan Repricing
The Chemours Company Announces Completion of Private Offering of $600,000,000 Aggregate Principal Amount of 8.000% Senior Unsecured Notes Due 2033
Chemours (NYSE:CC) Use Of Debt Could Be Considered Risky
(CC) - Analyzing Chemours's Short Interest
The Chemours To Go Ex-Dividend On November 15th, 2024 With 0.25 USD Dividend Per Share
Express News | Chemours Co - Proceeds to Redeem Euro-Denominated 4.000% Senior Notes Due 2026
Express News | The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2033
Why Chemours' (NYSE:CC) Earnings Are Better Than They Seem
Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 4% Dividend Yields
Chemours' Earnings and Revenues Surpass Estimates in Q3
RBC Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $25
Chemours Is Maintained at Equal-Weight by Morgan Stanley
Chemours Analyst Ratings
Express News | Chemours Co : Morgan Stanley Cuts Target Price to $25.00 From $30.00
Should You Investigate The Chemours Company (NYSE:CC) At US$20.58?
Barclays Maintains The Chemours(CC.US) With Hold Rating, Raises Target Price to $23
Mizuho Securities Maintains The Chemours(CC.US) With Hold Rating
Chemours Reports Q3 2024 Results and Strategic Update
Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $30